Baptist Health Recalls Daptomycin Bags Due to Sterility Concerns
Baptist Health Medical Towers Pharmacy is recalling 14 bags of Daptomycin 650 mg in 50 mL 0.9% NS due to a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury (such as sterility failure in IV products) are rated as Severe.
Plain-English summary
Baptist Health Medical Towers Pharmacy and Infusion Services in Little Rock, Arkansas, is recalling 14 bags of Daptomycin 650 mg in 50 mL 0.9% NS. The product is intended for intravenous use only. The recall was initiated because of a lack of sterility assurance for the affected units.
The affected product was distributed in Arkansas. The recall covers all product remaining within its expiry date. No specific lot numbers or dates are provided in the source text.
Consumers and healthcare providers should stop using the recalled product and contact the recalling firm for further instructions or a replacement.
The recalled product
- Product
- Daptomycin 650 mg in 50 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR
- Category
- Drug — IV Infusion
- Hazard
- Affected units
- 14
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All product remaining within expiry
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 38 recalled by Baptist Health Medical Towers Pharmacy and Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 38 products in this recall →Related recalls
Same manufacturer · Baptist Health Medical Towers Pharmacy and Infusion Services
See all →- SevereBaptist Health Pharmacy Recalls 1/2 Normal Saline Bags for Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighBaptist Health Recalls Deferoxamine Cassettes Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereBaptist Health Recalls Vancomycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighBaptist Health Recalls Four Bags of Piperacillin-Tazobactam Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereBaptist Health Recalls Hydromorphone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighDaptomycin Antibiotic Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighDaptomycin Injectable Antibiotic Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-22
- SevereWalgreens Recalls Daptomycin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereLincare Recalls Vancomycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Ceftriaxone Sodium IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SeverePharmakon Recalls Fentanyl Citrate Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20